As with antiretroviral combinations used in treatment, passive immunization of broadly neutralizing antibodies for prevention may require two or more bNAbs that target different parts of the virus. This graphic outlines the bNAb combinations being explored in early clinical studies.
Was this content helpful?
Tell us how we can improve the content.
Was this content helpful?
Thank you for your feedback!